Jasper Therapeutics, Inc. (JSPR) stock

JSPRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30

$13.37−1.39 (-9.42%)

Close on Nov 12, 2026Market cap $444.88MP/E –Yield –

Jasper Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

Jasper Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?